S100A12 and COVID-19: These data suggest that a plasma biomarker signature associated with pathogenic macrophage clusters in the lung and shared with RA synovitis (i.e., SPP1 and S100A12) might be useful for predicting the trajectory of disease severity and indicative of mechanism of pathogenesis of severe COVID-19.